-
Exploring a Novel Neurotrophic Factor to Protect the Nigrostriatal Dopaminergic System and Alleviate Motor Deficits
… brain delivery via nasal pathway make insulin stand out from other neuroprotective agents. If it shows to be effective in pre-clinical PD models, the timeline from clinical trial to patient use may be much shorter …
-
The Michael J. Fox Foundation for Parkinson's Research Announces Status as a Registered Canadian Charity
September 24, 2009
… as of the beginning of 2009, all donations to MJFF from Canadian residents are tax-deductible to the full … to share MJFF’s investment philosophy and highlights from its research investment portfolio. A ticketed gala …
-
Baseline Neuroimaging Characteristics of the Parkinson’s Progression Marker Initiative (PPMI) Parkinsons and Healthy Cohorts
June 17, 2012
… this on-going study, baseline 123-I Ioflupane SPECT scans from 20 imaging centers included 146 parkinson's subjects, … were higher in PD vs HV. SWEDDs were indistinguishable from HV on all quantitative SBR measures. Conclusions: …
-
Chaperone-mediated Autophagy to Counteract Alpha-synuclein Pathology
… PD brains and implant them in the brain of these models. Comparing models where LAMP2A is upregulated and in control … for Development: If successful in our goals, in future studies we seek to assess whether boosting the CMA pathway …
-
Michael J. Fox Honored with ‘Muhammad Ali Humanitarian Award for Courage’
September 13, 2019
… is not a declaration. It’s a dare.” These famous words from iconic boxer and humanitarian Muhammad Ali echoed … list of the night’s awardees including six youth leaders from around the world, Olympic swimming gold medalist Mark …
-
Friends of the Foundation: Tell Us Your Story
August 26, 2019
… Markers Initiative study, volunteers find support from one another. “Across the study sites, mini support … to walk the 500-mile Camino de Santiago together. “Matt, from Cincinnati, Ohio and Roger, then living in Monument, …